C3.ai(US:AI) Prnewswire·2025-10-07 19:00Core Viewpoint - The C3.ai class action lawsuit alleges that the company and its executives misled investors regarding the company's revenue outlook and growth potential, particularly in relation to CEO Thomas M. Siebel's health concerns, which were downplayed despite their significant impact on the company's performance [3][4]. Group 1: Allegations and Impact - The lawsuit claims that C3.ai created a false impression of reliable revenue projections and growth while minimizing risks associated with the CEO's health [3]. - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal year 2026 and reduced its revenue guidance for the full fiscal year, attributing these issues to leadership reorganization and the CEO's health, leading to a stock price drop of over 25% [4]. Group 2: Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased C3.ai securities during the class period to seek appointment as lead plaintiff, representing the interests of the class [5]. - The lead plaintiff is typically the investor with the greatest financial interest and can select a law firm to litigate the case, with the ability to share in any potential recovery not dependent on serving as lead plaintiff [5]. Group 3: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [6]. - The firm has been ranked 1 in securing monetary relief for investors in securities class action cases for four out of the last five years, highlighting its significant role in this legal domain [6].